Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial-Reference-Cited by-同舟云学术

Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial

Published:2016-09 Issue:9 Volume:3 Page:e426-e436
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Cohen Hannah,Hunt Beverley J,Efthymiou Maria,Arachchillage Deepa R J,Mackie Ian J,Clawson Simon,Sylvestre Yvonne,Machin Samuel J,Bertolaccini Maria L,Ruiz-Castellano Maria,Muirhead Nicola,Doré Caroline J,Khamashta Munther,Isenberg David A

Publisher

Elsevier BV

Subject

Hematology

Reference33 articles.

1. 14th International Congress in Antiphospholipid Antibodies Task Force report on antiphospholipid syndrome treatment trends;Erkan;Autoimmun Rev,2014

2. Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies;Ruiz-Irastorza;Lupus,2011

3. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus;Ruiz-Irastorza;Arch Intern Med,2004

4. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction and deep vein thrombosis: a critical review of the literature;Andreoli;Arthritis Care Res (Hoboken),2013

5. Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D-dimer;Eichinger;Clin Chem,2008

Cited by 352 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary manifestations of systemic lupus erythematosus;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Comparing clinical outcomes of vitamin K antagonists vs non-vitamin K antagonists in anticoagulant therapy for mesenteric venous thrombosis;Journal of Vascular Surgery: Venous and Lymphatic Disorders;2024-09

3. Dilemmas in the diagnosis and management of antiphospholipid syndrome;Journal of Thrombosis and Haemostasis;2024-08

4. Thrombotic antiphospholipid syndrome: From guidelines to clinical management;Medicina Clínica;2024-08

5. Deciphering Mechanisms, Prevention Strategies, Management Plans, Medications, and Research Techniques for Strokes in Systemic Lupus Erythematosus;Medicines;2024-07-31